HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Relationship between parameters of hemostasis and manifestations of the metabolic syndrome in men with mild and moderate hypertension].

AbstractAIM:
To study the relationship between major hemostasis parameters and hypertriglyceridemia with or without insulin resistance/hyperinsulinemia in men suffering from mild or moderate arterial hypertension.
MATERIAL AND METHODS:
Major hemostasis parameters including fibrinogen level, coagulation factor VII activity and fibrinolytic activity were analysed in groups of men with moderate or mild AH who had normal or elevated triglycerides level regarding presence or absence of insulin resistance/hyperinsulinemia.
RESULTS:
High factor VII activity was found in both groups with insulin resistance irrespective of their triglycerides level. Patients with insulin resistance combined with hypertriglyceridemia had low fibrinolytic activity.
CONCLUSION:
In men with metabolic syndrome components insulin resistance is accompanied with activation of coagulation external pathway, whereas combination of insulin resistance with hypertriglyceridemia was associated with hypofibrinolysis.
AuthorsL A Ratnikova, V A Metel'skaia, M N Mamedov, A M Olfer'ev, N V Perova
JournalTerapevticheskii arkhiv (Ter Arkh) Vol. 72 Issue 9 Pg. 13-6 ( 2000) ISSN: 0040-3660 [Print] Russia (Federation)
Vernacular TitleSviaz' mezhdu parametrami gemostaza i proiavleniiami metabolicheskogo sindroma u muzhchin s miagkoĭ i umerennoĭ gipertonieĭ.
PMID11076408 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Blood Glucose
  • Insulin
  • Triglycerides
  • Factor VII
  • Cholesterol
Topics
  • Adult
  • Blood Glucose (analysis)
  • Cholesterol (blood)
  • Factor VII (analysis)
  • Fibrinolysis
  • Hemostasis
  • Humans
  • Hypertension (blood, complications)
  • Hypertriglyceridemia (complications)
  • Insulin (blood)
  • Insulin Resistance
  • Male
  • Sex Factors
  • Syndrome
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: